Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Biometrical Journal. Biometrische Zeitschrift|November 10, 2011
Development of gatekeeping strategies in confirmatory clinical trialsAlex Dmitrienko, Brian A Millen, Thomas Brechenmacher, et al.Statistical Methods in Medical Research|April 1, 2020
Optimized multiple testing procedures for nested sub-populations based on a continuous biomarkerAlexandra Christine Graf, Dominic Magirr, Alex Dmitrienko, et al.Statistics in Medicine|August 24, 2006
Challenge of multiple co-primary endpoints: a new approachChristy Chuang-Stein, Paul Stryszak, Alex Dmitrienko, et al.Pharmaceutical Statistics|March 24, 2022
A two-stage adaptive clinical trial design with data-driven subgroup identification at interim analysisSarah E Johnston, Ilya Lipkovich, Alex Dmitrienko, et al.Journal of Biopharmaceutical Statistics|April 5, 2014
Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trialAklilu Habteab Ghebretinsae, Geert Molenberghs, Alex Dmitrienko, et al.Therapeutic Innovation & Regulatory Science|September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference ConsiderationsBrian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.Therapeutic Innovation & Regulatory Science|September 19, 2018
Statistical Considerations for an Adaptive Design for a Serious Rare DiseaseKaushik Patra, Bruce A C Cree, Eliezer Katz, et al.Journal of Biopharmaceutical Statistics|September 18, 2015
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic reviewThomas Ondra, Alex Dmitrienko, Tim Friede, et al.Critical Care Medicine|August 13, 2005
LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsisBernhardt G Zeiher, Jay Steingrub, Pierre-Francois Laterre, et al.Journal of Biopharmaceutical Statistics|December 15, 2017
An enhanced mixture method for constructing gatekeeping procedures in clinical trialsGeorge Kordzakhia, Thomas Brechenmacher, Eiji Ishida, et al.Pageof 7